Humana Inc.
HUM NYSEHealthcare ★★★★★Latest Earnings
Date
Jul 29, 2026
ET
EPS Est.
7.27
EPS Actual
7.61
Revenue Est.
$40.58B
Revenue Actual
$40.87B
Next Earnings Report
Date
Nov 4, 2026 · Wed
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
-0.93
Revenue Est.
$40.87B
Company Overview
Humana Inc. (ticker HUM) is listed on NYSE with a market cap of about $45.49B. Its next earnings report (FY2026 Q3) is expected on Nov 4, 2026 (ET), Pre-market, with consensus EPS of -0.93. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Feb 1, 2023 → Jul 29, 2026
Feb 1, 2023Range: -3.96 ~ 11.58Jul 29, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 29, 2026 | -- | 7.27 | 7.61 | $40.58B | $40.87B |
| Apr 29, 2026 | -- | 10.24 | 10.31 | $39.37B | $39.65B |
| Feb 11, 2026 | -- | -4.00 | -3.96 | $32.04B | $32.52B |
| Nov 5, 2025 | -- | 2.93 | 3.24 | $32B | $32.65B |
| Jul 30, 2025 | -- | 5.92 | 6.27 | $31.87B | $32.39B |
| Apr 30, 2025 | -- | 10.07 | 11.58 | $32.2B | $32.11B |
| Feb 11, 2025 | -- | -2.23 | -2.16 | $28.81B | $29.21B |
| Oct 30, 2024 | -- | 3.40 | Above forecast↑4.16 | $28.68B | $29.4B |
| Jul 31, 2024 | -- | 5.85 | Above forecast↑6.96 | $28.52B | $29.54B |
| Apr 24, 2024 | -- | 6.12 | Above forecast↑7.23 | $28.52B | $29.61B |
| Jan 25, 2024 | -- | -0.07 | Below forecast↓-0.11 | $25.54B | $26.46B |
| Nov 1, 2023 | -- | 7.16 | 7.78 | $25.55B | $26.42B |
| Aug 2, 2023 | -- | 8.82 | 8.94 | $26.23B | $26.75B |
| Apr 26, 2023 | -- | 9.27 | 9.38 | $26.19B | $26.74B |
| Feb 1, 2023 | -- | 1.46 | 1.62 | $22.48B | $22.44B |
Original Filings (SEC)
10-Q2026-07-29 ↗
8-K2026-07-29 ↗
8-K2026-07-29 ↗
8-K2026-06-01 ↗
8-K2026-05-19 ↗
10-Q2026-04-29 ↗
8-K2026-04-29 ↗
8-K2026-04-20 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
